Latest Announcements

Ladenburg Thalmann Expands Biotechnology Equity Research Team with the addition of two senior analysts, Rick Bienkowski, Ph.D. and Caroline Palomeque NEW YORK, NY - June 4, 2026 - Ladenburg Thalmann &... Read Article

Ladenburg Thalmann Expands Investment Banking Platform with Biotechnology Specialist Dr. Aydin Huseynov, M.D., CFA NEW YORK — April 27, 2026 — Ladenburg Thalmann & Co. Inc., a... Read Article

Ladenburg Thalmann Expands Healthcare Investment Banking Platform with Hire of Meredith Sondler-Bazar NEW YORK, NY - December 12th, 2025 - Ladenburg Thalmann & Co. Inc. ("Ladenburg Thalmann"), an SEC... Read Article

Ladenburg Thalmann Expands Equity Research Platform with Hire of Veteran REIT Analyst Floris van Dijkum Strategic hire deepens Ladenburg's research capabilities, adds REIT vertical and unlocks cross-platform... Read Article

Ladenburg Thalmann Appoints Daniel Blood as Co-Head of Investment Banking and Head of Financial Institutions Group35+ year veteran tapped to oversee expansion of investment banking division, strengthening of key... Read Article

Mar. 18, 2025 11:13 AM ETB2i Digital will showcase AI-focused innovators ahead of the May 21, 2025, event in New York City, facilitating connections between forward-thinking companies and strategic investorsNEW... Read Article

FOR IMMEDIATE RELEASE Ladenburg Thalmann and Osaic, Inc. to host Virtual Non-Deal Road Show with WEC Energy Group New York, NY - February 18th, 2025 - Ladenburg Thalmann & Co. Inc. announced it will... Read Article

FOR IMMEDIATE RELEASE New York, NY - February 14, 2025 - Ladenburg proudly announces the launch of its newly redesigned website, www.ladenburg.com. The site has been revamped with a modern design, enhanced... Read Article

Transaction Information SoundHound AI, Inc. (Nasdaq: SOUN) announced that it has established an at-the-market equity offering program under which it may, from time to time, sell shares of its common stock having... Read Article

Transaction Information Calidi Biotherapeutics Inc. (NYSE American: CLDI) announced the closing of its public offering of 5,000,000 shares of common stock at $0.85 per share for gross proceeds of approximately... Read Article

FOR IMMEDIATE RELEASE Ladenburg Thalmann Successfully Hosts Virtual Oncology Innovators & Investors Symposium New York, NY - December 12, 2024 - Ladenburg Thalmann & Co. Inc. today... Read Article

Transaction Information Palisade Bio, Inc (NASDAQ: PALI) announced the closing of its underwritten public offering for gross proceeds of approximately $5 million priced at-market under Nasdaq rules. Ladenburg... Read Article